These outcomes, together with a earlier report displaying that a small-molecule ACKR3 agonist CCX771 displays anxiolytic-like behavior in mice,2 aid the concept of targeting ACKR3 as a unique way to modulate the opioid program, which could open up new therapeutic avenues for opioid-relevant disorders. At that time, Microsoft Advertising https://soichiror257uze6.plpwiki.com/user